Association of oral glucocorticoid use with an increased risk of acute pancreatitis: A population-based nested case-control study

JAMA Internal Medicine

Volumn 173, Issue 6, 2013, Pages 444-449

  Sadr Azodi, Omid ^a   Mattsson, Fredrik ^a   Bexlius, Tomas Sjöberg ^a   Lindblad, Mats ^a   Lagergren, Jesper ^a,b   Ljung, Rickard ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BETAMETHASONE; BUDESONIDE; CORTISONE; DEXAMETHASONE; FLUTICASONE; GLUCOCORTICOID; HYDROCORTISONE; METHYLPREDNISOLONE; MOMETASONE FUROATE; PREDNISONE;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; DRUG USE; FEMALE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; GLUCOCORTICOIDS; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; ODDS RATIO; PANCREATITIS; REGISTRIES; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SWEDEN; TIME FACTORS;

EID: 84875762190     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.2737     Document Type: Article

References (42)

1. Frossard JL, Steer ML, Pastor CM. Acute pancreatitis. Lancet. 2008;371(9607): 143-152.
2. Gaisano HY, Gorelick FS. New insights into the mechanisms of pancreatitis. Gastroenterology. 2009;136(7):2040-2044.
3. Oskarsson V, Mehrabi M, Orsini N, et al. Validation of the harmless acute pancreatitis score in predicting nonsevere course of acute pancreatitis. Pancreatology. 2011;11(5):464-468.
4. Lankisch PG, Breuer N, Bruns A, Weber-Dany B, Lowenfels AB, Maisonneuve P. Natural history of acute pancreatitis: a long-term population-based study. Am J Gastroenterol. 2009;104(11):2797-2805.
5. Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007; 5(6):648-661.
6. Vinklerová I, Procházka M, Procházka V, Urbánek K. Incidence, severity, and etiology of drug-induced acute pancreatitis. Dig Dis Sci. 2010;55(10):2977-2981.
7. Spanier BW, Tuynman HA, van der Hulst RW, Dijkgraaf MG, Bruno MJ. Acute pancreatitis and concomitant use of pancreatitis-associated drugs. Am J Gastroenterol. 2011;106(12):2183-2188.
8. van Staa TP, Leufkens HG, Abenhaim L, Begaud B, Zhang B, Cooper C. Use of oral corticosteroids in the United Kingdom. QJM. 2000;93(2):105-111.
9. Overman RA, Yeh JY, Deal CL. Prevalence of oral glucocorticoid usage in the United States: a general population perspective [published online July 17, 2012]. Arthritis Care Res (Hoboken). doi:10.1002/acr.21796.
10. Schäcke H, Döcke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2002;96(1):23-43.
11. Renkes P, Petitpain N, Cosserat F, Bangratz S, Trechot P. Can roxithromycin and betamethasone induce acute pancreatitis? a case report. JOP. 2003;4(5):184-186.
12. Jain R, Ramanan SV. Iatrogenic pancreatitis: a fatal complication in the induction therapy for acute lymphocytic leukemia. Arch Intern Med. 1978;138(11):1726.
13. Keefe M, Munro F. Acute pancreatitis: a fatal complication of treatment of bullous pemphigoid with systemic corticosteroids. Dermatologica. 1989;179(2):73-75.
14. Levine RA, McGuire RF. Corticosteroid-induced pancreatitis: a case report demonstrating recurrence with rechallenge.AmJ Gastroenterol. 1988;83(10):1161-1164.
15. Yoshizawa Y, Ogasa S, Izaki S, Kitamura K. Corticosteroid-induced pancreatitis in patients with autoimmune bullous disease: case report and prospective study. Dermatology. 1999;198(3):304-306.
16. Felig DM, Topazian M. Corticosteroid-induced pancreatitis. Ann Intern Med. 1996; 124(11):1016.
17. Blomgren KB, SundströmA, Steineck G, Genell S, Sjöstedt S, Wiholm BE. A Swedish case-control network for studies of drug-induced morbidity-acute pancreatitis. Eur J Clin Pharmacol. 2002;58(4):275-283.
18. Makol A, Petri M. Pancreatitis in systemic lupus erythematosus: frequency and associated factors-a review of the Hopkins Lupus Cohort. J Rheumatol. 2010; 37(2):341-345.
19. Chawla S, Atten MJ, Attar BM. Acute pancreatitis as a rare initial manifestation of Wegener's granulomatosis: a case based review of literature. JOP. 2011; 12(2):167-169.
20. Ljung R, Lagergren J, Bexelius TS, Mattsson F, Lindblad M. Increased risk of acute pancreatitis among tetracycline users in a Swedish population-based casecontrol study. Gut. 2012;61(6):873-876.
21. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659-667.
22. The Swedish National Board of Health and Welfare. The Swedish Patient Register. http://www.socialstyrelsen.se/register/halsodataregister/ patientregistret.Accessed August 6, 2012.
23. Razavi D, Ljung R, Lu Y, Andrén-Sandberg A, Lindblad M. Reliability of acute pancreatitis diagnosis coding in a National Patient Register: a validation study in Sweden. Pancreatology. 2011;11(5):525-532.
24. Statistics Sweden. Register of Total Population. http://www.scb.se/Pages/ SubjectArea-1954.aspx. Accessed August 6, 2012.
25. Wettermark B, Hammar N, Fored CM, et al. The new Swedish Prescribed Drug Register-opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726-735.
26. World Health Organization. WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atc-ddd-index/. Accessed August 6, 2012.
27. The Swedish National Board of Health and Welfare. Swedish Causes of Death Register-Bortfall och kvalitet i dödsorsaksregistret. http://www. socialstyrelsen.se/register/dodsorsaksregistret/bortfallochkvalitet. Accessed August 6, 2012.
28. Barlow L, Westergren K, Holmberg L, Talbäck M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 2009;48(1):27-33.
29. Statistics Sweden. The Swedish Register of Education. http://www.scb.se/Pages/SubjectArea-3930.aspx. Accessed August 6, 2012.
30. Wang MH, Shugart YY, Cole SR, Platz EA. A simulation study of control sampling methods for nested case-control studies of genetic and molecular biomarkers and prostate cancer progression. Cancer Epidemiol Biomarkers Prev. 2009;18(3):706-711.
31. Rothman K, Greenland S, Lash T. Modern Epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
32. Kleinbaum D, Klein M. Logistic Regression: A Self-Learning Text. 2nd ed. New York, NY: Springer; 2002.
33. Olsen J. Register-based research: some methodological considerations. Scand J Public Health. 2011;39(3):225-229.
34. Dandona P, Junglee D, Katrak A, Fonseca V, Havard CW. Increased serum pancreatic enzymes after treatment with methylprednisolone: possible evidence of subclinical pancreatitis. Br Med J (Clin Res Ed). 1985;291(6487):24.
35. Kristiansen L, Grønbaek M, Becker U, Tolstrup JS. Risk of pancreatitis according to alcohol drinking habits: a population-based cohort study. Am J Epidemiol. 2008;168(8):932-937.
36. Sadr-Azodi O, Andrén-Sandberg A, Orsini N, Wolk A. Cigarette smoking, smoking cessation and acute pancreatitis: a prospective population-based study. Gut. 2012;61(2):262-267.
37. Sadr-Azodi O, Orsini N, Andrén-Sandberg A, Wolk A. Abdominal and total adiposity and acute pancreatitis-a population-based study [published online November 13, 2012]. Am J Gastroenterol. doi:10.1038/ajg.2012.381.
38. Oskarsson V, Sadr-Azodi O, Orsini N, Andrén-Sandberg A, Wolk A. Vegetables, fruit and risk of non-gallstone-related acute pancreatitis: a population-based prospective cohort study [published online June 27, 2012]. Gut. doi:10.1136/gutjnl-2012-302521.
39. Buttgereit F, Brand MD, Burmester GR. Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy. Biochem Pharmacol. 1999;58(2):363-368.
40. Cerasoli F Jr. Developing the ideal inhaled corticosteroid. Chest. 2006;130(1) (suppl):54S-64S.
41. Downie WW, Dixon JS, Lowe JR, Rhind VM, Leatham PA, Pickup ME. Adrenocortical suppression by synthetic corticosteroid drugs: a comparative study of prednisolone and betamethasone. Br J Clin Pharmacol. 1978;6(5):397-399.
42. Jaffuel D, Roumestan C, Balaguer P, et al. Correlation between different gene expression assays designed to measure trans-activation potencies of systemic glucocorticoids. Steroids. 2001;66(7):597-604.